School of Medicine
Showing 1-75 of 75 Results
-
Andrew Young Chang, MD
Ph.D. Student in Epidemiology and Clinical Research, admitted Summer 2020
Current Research and Scholarly InterestsMy research interests center around the epidemiology, environmental determinants, and health services dimensions of heart disease, with an emphasis on vulnerable populations, both international and domestic. Current projects include the development of novel care quality metrics for use in rheumatic heart disease in East Africa, testing of low sodium salt substitutes in South Asia, and describing the cardiovascular impacts of cyclical climate change-associated major environmental events.
-
Benjamin I. Chung
Associate Professor of Urology
Current Research and Scholarly InterestsRenal cell carcinoma and prostate cancer outcomes research and epidemiology.
-
Max K. Clary
MD Student, expected graduation Spring 2026
Research Asst., Peds/Hospital MedicineBioMax K. Clary is pursuing an MD at Stanford School of Medicine.
Max earned his bachelor’s degree in Chemistry at Lewis & Clark College as a Pamplin Honor Society Fellow and his MPH in Global Health at the George Washington University. He has worked on several global health projects in India, Pakistan and East Africa. He is the founder of several impact-centered organizations such as Organic Route, a company aimed at improving agricultural supply chains and the distribution of healthy foods in rural areas of East Africa.
Max dreams of pursuing a dual MD/MBA degree and eventually utilizing his background in business, public health and medicine to create innovative healthcare solutions that are equitable, prevention-focused and individually-tailored. -
Henry Corbett Cousins
MD Student, expected graduation Spring 2024
Ph.D. Student in Biomedical Informatics, admitted Autumn 2021
MSTP StudentBioHenry is an MD-PhD candidate and Knight-Hennessy Scholar in the Medical Scientist Training Program and the Biomedical Informatics Program, where he is advised by Professor Russ Altman. He develops machine-learning methods to study the effects of complex genetic variation on human disease mechanisms, with focus on neurological and ophthalmic disorders. His goal is to translate genomic discoveries into disease-modifying therapies.
He received an AB summa cum laude from Harvard University in 2017, where he studied genetic mechanisms of retinal development with Professor Joshua Sanes. He then graduated with an MPhil with distinction from the University of Cambridge as a Gates Cambridge Scholar. He previously worked at Leaps by Bayer and the Massachusetts Eye and Ear Infirmary and has received several awards related to research and teaching.
